Available online Dec 18, 2019.
[ Original ] Volume 28, Issue 3, 2019, Pages 218-223
INTRODUCTION: The coexistence of dyslipidaemia and hypertension results in enhanced atherosclerosis.
Adequate treatment of dyslipidaemia in hypertensive patients is thus essential for reducing the burden of
OBJECTIVE: To determine the prevalence of dyslipidaemia among hypertensives and evaluate lipid treatment
status of patients with dyslipidaemia in a tertiary hospital in Nigeria.
METHODS: This cross-sectional comparative study was done between May, 2015 and June, 2016 in a tertiary
hospital in Nigeria. The serum lipid levels of adult patients with hypertension and controls without
hypertension were determined. Lipid treatment status of patients with dyslipidaemia were also reviewed.
Serum lipid levels were analyzed using spectrophotometric methods.
RESULTS: The study included 200 adult hypertensive patients and 100 control participants. The mean age (SD)
was 56.3 (6.9) years and 54.9 (8.3) years with range 41-68 and 44-69 years for patients and controls
respectively. Eighty-eight (44.0%) hypertensive patients and 23(23.5%) of the control group were found to have
dyslipidaemia. Out of the 60(68.2%) patients with elevated LDL-C, 32(53.3%) had LDL-C >4.1mmol/L, out of
which only 8(25%) were on antilipid medication.
CONCLUSION: Over one-third of studied hypertensive patients had dyslipidaemia and only a quarter of those
who needed antilipids were on the medication. Greater awareness is needed both in the medical and patient
communities in order to effectively manage dyslipidaemic hypertension, and hence aid in ameliorating the
burden of cardiovascular diseases.
Subscribe to have full access to PDF format of all articles and get print copy of Nigerian Medical Journal.
Volume 28 | Issue 3
Page Nos. 218-223
Online since Dec 17, 2019